Constellation Pharmaceuticals

Entry	Author	Date	Location
Option to Buy: The New Face of Biotech Funding?	Arlene Weintraub	02/13/12	National
Flagship, Joule, Constellation, and More of The Week’s Boston Dealmakers	Erin Kutz	01/18/12	Boston
Genentech Pours $95M Into Constellation’s Drug Platform	Arlene Weintraub	01/17/12	Boston
Constellation Pharma Raises More Money and Further Defines Pipeline	Arlene Weintraub	06/17/11	Boston
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News	Erin Kutz	06/10/11	Boston
General Compression Pulls In $20.4M, Constellation Nabs $15M, PolyRemedy Wraps Up $20M, & More Boston-Area Deals News	Erin Kutz	06/08/11	Boston
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S.	Luke Timmerman	06/07/11	National
Constellation Pharma Raises $15M for Epigenetic Drugs	Gregory T. Huang	06/06/11	Boston
Constellation Pharmaceuticals Garners $15,000,000 Series B Funding	VentureDeal	06/06/11	Boston
Tom Maniatis, Molecular Biology Pioneer, Seeks to Help Build a Kendall Square in NYC	Luke Timmerman	04/05/11	New York
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41	Luke Timmerman	02/10/11	Boston
Shots from the Front Row of Boston’s War on Cancer Event	Ryan McBride	10/22/10	Boston
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News	Erin Kutz	10/15/10	Boston
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer	Luke Timmerman	10/14/10	Boston
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D	Luke Timmerman	10/05/10	Boston
MIT Cancer Research Star Tyler Jacks Takes Closing Keynote Role at Xconomy Forum	Luke Timmerman	09/28/10	Boston
What Is Boston Doing for the War on Cancer? Find Out at Xconomy Forum on October 20	Luke Timmerman	08/25/10	Boston
Third Rock Ventures, Firm With Hunger for Audacious Biotech Ideas, Sets up SF Shop	Luke Timmerman	08/12/10	San Francisco
VC Investment in New England Declines in Second Quarter (Two Out of Three Surveys Say); Top 10 Deals Dominated by Biotech	Gregory T. Huang	07/19/10	Boston
Flagship Plans $300M New Fund, Boston TechStars Pitch to Area Investors, AutoVirt Raises $1.5M, & More Boston-Area Deals News	Erin Kutz	06/09/10	Boston
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News	Erin Kutz	06/04/10	Boston
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma	Ryan McBride	06/02/10	Boston
Constellation Pharmaceuticals Lands $22,000,000 Series B Funding Round	VentureDeal	06/02/10	Boston
Epizyme Entices Broad Institute Player, Robert Gould, to Take Over as CEO	Ryan McBride	03/24/10	Boston
Genetix Pharma Raises $35M from Third Rock, Genzyme for Gene Therapy	Ryan McBride	03/12/10	Boston
Epizyme Snags $32M Round to Make Drugs Against Cancer and More	Luke Timmerman	10/07/09	Boston
Funding for Massachusetts Startups Slower, but Still Strong, in August; Early-Stage Deals Predominate	Robert Buderi	09/14/09	Boston
Pickett to Relinquish Biogen Idec Board Seat, New Financing for iWalk, Genocea Goes After Vaccine Market, & More Boston-Area Life Sciences News	Rebecca Zacks	09/02/09	Boston
New Constellation Pharma CEO Gives Expected Timeline for Epigenetics Firm’s Cancer Drug Research	Ryan McBride	09/01/09	Boston
Navinet and Vitality use Internet for Health, Constellation Gets to Series A, and Other Boston-Area Life Sciences News	Eric Hal Schwartz	08/19/09	Boston
Page 1 of 2	next page »

Entry

Author

Date

Location

Option to Buy: The New Face of Biotech Funding?

Arlene Weintraub

02/13/12

National

Flagship, Joule, Constellation, and More of The Week’s Boston Dealmakers

Erin Kutz

01/18/12

Boston